Naviaux and his team at the University of California San Diego School of Medicine have uncovered key metabolic changes that occur in children with autism, shedding light on new early detection and prevention strategies. Their research suggests that metabolic differences related to the cell danger response may play a significant role in the development of autism. By targeting ATP signaling pathways with drugs like suramin, there is hope for managing the symptoms of ASD. This groundbreaking study, published in Communications Biology, opens the door to a potential drug renaissance in autism treatment. The findings offer hope for improved outcomes for individuals with autism spectrum disorder.
https://medicalxpress.com/news/2024-05-metabolism-autism-reveals-developmental.html